Search
PURINETHOL 50 MG, Comprimé
Details
| --- | Description |
|---|---|
| Pack | Boîte de 25 |
| Strength (Dosage) | 50 MG |
| Laboratory | GSK MAROC |
| Ingredients | Mercaptopurine |
| Therapeutic class | ANTINEOPLASIQUE CYTOTOXIQUE |
| ATC code | L01BB02 |
| PPH | $2.97 |
| PPV | $4.75 |
| Refundable | Yes |
| Refund base | $4.75 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | PURINETHOL est indiqué dans le traitement de la leucémie aiguë chez l'adulte, l'adolescent et l'enfant. Il peut être utilisé dans les indications suivantes : · leucémies aiguës lymphoblastiques (LAL) · leucémies aiguës myéloblastiques (LAM) |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem